Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
10.89
-0.29 (-2.59%)
At close: Nov 20, 2026, 4:00 PM EST
10.91
+0.02 (0.18%)
After-hours: Nov 20, 2026, 7:30 PM EST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.46 billion as of November 20, 2026. Its market cap has decreased by 23.07% in one year.
Market Cap
1.46B
Enterprise Value
1.49B
1-Year Change
-23.07%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.46B, an increase of 146.51%. That is a compound annual growth rate of 8.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.41B | -38.84% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.52B |
| Vir Biotechnology | 1.52B |
| Damora Therapeutics | 1.50B |
| Kailera Therapeutics | 1.50B |
| Precigen | 1.49B |
| Nurix Therapeutics | 1.49B |
| Nanobiotix | 1.45B |
| uniQure | 1.42B |